RxDoctor Payments Data

Jared West, MD

General Practice · Casselberry, FLNPI 1467608877

Payments from drug & device makers

$2,499in general payments, 2019–2025

Across 127 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$657
  • Bayer$427
  • Boehringer Ingelheim$323
  • Amgen$236
  • Lilly USA, LLC$158
  • Vanda Pharmaceuticals Inc.$127
  • plus $572 from 11 others

What the payments were for

  • Food & beverage$2,499100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,499 in reported general payments places this provider in the 90th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$19,249
Medicare patients
43
Services billed
520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin180$261,632
OzempicSemaglutide163$203,891
EliquisApixaban66$80,685
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$66,880
FarxigaDapagliflozin Propanediol52$52,056
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$17,603
JanuviaSitagliptin Phosphate12$17,166
XareltoRivaroxaban13$16,154
Breo ElliptaFluticasone/Vilanterol15$15,599
Repatha SyringeEvolocumab16$14,297
SymbicortBudesonide/Formoterol Fumarate21$9,035
Lantus SolostarInsulin Glargine,hum.Rec.Anlog51$8,335
Praluent PenAlirocumab13$6,476
Albuterol Sulfate HfaAlbuterol Sulfate159$6,210
Sucralfate16$5,115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$323$261,632180 claims
Novo NordiskOzempic$127$203,891163 claims
GSKTrelegy Ellipta, Breo Ellipta$76$82,47959 claims
PfizerEliquis$21$80,68566 claims
AstraZenecaFarxiga, Symbicort$657$61,09173 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,901 general practice providers in Florida.

Other general practice in Casselberry

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →